What USP Botanical Monographs Actually Require — And Why Most CoAs Don't Show It
USP botanical monographs specify 4–6 tests each. Here's what identity, assay, and purity testing should look like — and what to ask your raw material supplier.
Key Takeaway
USP botanical monographs specify 4–6 tests each. Here's what identity, assay, and purity testing should look like — and what to ask your raw material supplier.
Every week, our sample receiving team in Countryside, IL processes botanical raw materials that arrive with CoAs stamped “Meets USP specifications.” And almost every week, we pull one of those CoAs apart and find the same problem: it cites the monograph, but the actual testing data underneath is incomplete.
That’s not a vendor compliance issue — it’s a documentation literacy issue. Most brands and their suppliers don’t know how many tests a USP botanical monograph actually specifies, what each test is supposed to detect, or which ones are routinely omitted on supplier-issued CoAs. The result is a paper trail that looks compliant on its face and falls apart the moment an FDA investigator or a quality auditor asks the right question.
USP has published monographs for more than 60 botanical raw materials in the United States Pharmacopeia–National Formulary (USP-NF) and the Dietary Supplements Compendium (DSC). Each monograph is a multi-page technical specification. One line on a CoA saying “Conforms to USP” doesn’t substitute for actually running it.
What a USP Botanical Monograph Actually Contains
Most people know that USP monographs include identity testing. What they often don’t realize is that a typical botanical monograph also specifies an assay method for marker or active compounds, a purity section with limits on foreign matter and pesticides, a heavy metals test — increasingly referenced to USP <232>/<233> — and microbial acceptance criteria referenced to USP <61>, <62>, and <2021>.
Take Valerian Root as a straightforward example. The USP monograph specifies HPTLC for botanical identification, HPLC for determination of valerenic acid content (minimum 0.3% in the dried root), and references USP <2021> for microbial limits. It also sets a total heavy metals limit under USP <231> — though in practice, a facility operating under 21 CFR Part 111 GMP requirements is better served by the elemental-specific ICP-MS methodology of USP <232>/<233>, which sets individual limits for lead, arsenic, cadmium, and mercury rather than a single blunt colorimetric threshold.
Five distinct test categories in one monograph. A CoA that says “Meets USP” without documenting results for each of them is, at best, incomplete.
This matters beyond good lab hygiene. Under 21 CFR Part 111.75(a)(1)(i), you are required to test every incoming raw material component for identity before use in manufacturing. The regulation doesn’t mandate USP methods specifically — but if your CoA references a USP monograph, you’ve effectively committed to that specification. An FDA investigator reviewing your raw material testing records will hold you to the standard you cited.
Why Marker Compound Assays Don’t Confirm Botanical Identity
This is where well-intentioned suppliers go wrong most often. They run an HPLC assay, confirm their Panax ginseng extract hits the ginsenoside Rb1 + Rg1 content specification, and mark the identity section as passing. But a marker compound assay is a potency test — not an identity test.
A material can pass a ginsenoside assay if someone spiked a cheap filler with purified ginsenoside concentrate. It can pass a hypericin assay while containing mostly non-St. John’s Wort plant material that was spiked with synthetic hypericin. The marker is present. The plant identity is not confirmed. This distinction is exactly why USP botanical monographs specify HPTLC as the identification method, not HPLC.
High-performance thin-layer chromatography produces a visual chromatographic fingerprint of the entire extract, compared against reference standards and authenticated botanical reference materials. You’re looking at a full lane of separated compounds, not a single peak. It’s considerably harder to fake a complete fingerprint than to hit a single assay threshold.
For high-risk botanicals — anything where species substitution is commercially motivated, which includes ginseng, echinacea, black cohosh, and valerian — DNA barcoding is increasingly used as a complement to HPTLC. DNA barcoding isn’t currently listed as a USP method, but FDA recognizes it as a scientifically valid identification tool. It adds genomic species confirmation that chemical fingerprinting alone can’t always provide, particularly in powdered forms where tissue morphology is lost and multiple source materials may have been blended.
The gold standard for high-risk material: HPTLC for fingerprint identity, HPLC for marker compound assay, and DNA barcoding as a confirmatory check when species substitution risk is elevated. These three methods answer different questions. Treating any one of them as sufficient on its own is an analytical shortcut.
Six Botanicals, Six Monographs, Six Different Testing Profiles
Let me walk through the testing requirements for six of the most commonly purchased botanical raw materials in the US supplement market.
Panax Ginseng Root. Identification by HPTLC. Assay by HPLC for total ginsenosides Rb1 and Rg1 (minimum 0.4% combined in the dried root). Ginseng is a high-value material; its ginsenoside profile makes it a prime candidate for substitution with closely related Panax species or dilution with non-Panax fillers. HPTLC and DNA barcoding together provide meaningful confidence here.
Valerian Root. HPTLC identification. HPLC assay for valerenic acid (minimum 0.3% in the dried root). Worth noting: valerian also contains valepotriates, which are present in the fresh root but degrade rapidly during drying and storage. Their absence in a properly dried powder is normal — but a knowledgeable analytical testing laboratory will note this in the report so it isn’t misread as a quality failure.
St. John’s Wort. HPTLC identification. HPLC for total hypericins expressed as hypericin (minimum 0.04% in the dried aerial parts). Adulteration with related Hypericum species is well-documented in published literature. A chemical-only identity check won’t catch all substitutions here; DNA barcoding adds meaningful resolution.
Echinacea. Three commercially relevant species — E. purpurea, E. angustifolia, and E. pallida — each have their own USP monograph with different specified marker compounds. E. purpurea aerial parts are assayed for cichoric acid (minimum 0.6%); E. angustifolia root is assayed for echinacoside. A CoA that says “Echinacea — Meets USP” without specifying the species and the applicable monograph is essentially useless. This is one of the more common documentation failures we see from overseas suppliers.
Black Cohosh. HPTLC identification. HPLC assay for triterpene glycosides expressed as 23-epi-26-deoxyactein (minimum 0.4% in the dried rhizome). Black cohosh has one of the most documented adulteration histories in the botanical industry — multiple investigations by FDA, NSF International, and AHPA have found samples containing Asian Actaea species substituted for the North American A. racemosa. If there’s one botanical where you don’t skip the HPTLC fingerprint, it’s this one.
Saw Palmetto Berry. HPTLC for identity. GC for fatty acid content, with lauric acid and specified ethyl ester content within defined ranges. Saw palmetto is commonly sold as a lipidic extract standardized to fatty acids, and the fatty acid profile itself functions as the identity marker — but it’s GC methodology, not HPLC, that USP specifies. Brands relying on supplier HPLC certificates for saw palmetto may be using the wrong method to confirm USP conformance and wouldn’t know it from the certificate alone.
The Four Questions Every Incoming Botanical CoA Should Answer
When you receive a botanical CoA claiming USP compliance, four specific questions tell you whether the testing was actually done or just referenced:
Which monograph revision was used? USP monographs are revised on a rolling basis. A CoA referencing methodology from a superseded revision may not reflect current acceptance criteria — and in the event of an FDA audit, “we relied on the supplier’s CoA” is not a complete defense.
What identification method was used? “Organoleptic” or “visual inspection” does not satisfy the HPTLC requirements specified in most USP botanical monographs. If the identification method field on the CoA doesn’t say HPTLC (or an equivalently specific instrumental method), the USP identity standard wasn’t met.
Was the marker compound assay performed by HPLC? Or was the reported content extrapolated from a colorimetric or UV-spectrophotometric method? The latter is not acceptable as a USP-compliant assay for most botanical ingredients and tends to overestimate content in complex plant matrices.
Were heavy metals tested to USP <232>/<233> or only USP <231>? The older colorimetric method in <231> sets only a total heavy metals limit. It doesn’t distinguish between lead, arsenic, cadmium, and mercury individually. For botanicals with known heavy metal accumulation risk — root-based materials grown in high-deposition soils in South and Southeast Asia especially — individual elemental analysis by ICP-MS is the appropriate methodology. A supplier who ran only a <231> colorimetric test may have missed a lead or cadmium spike that wouldn’t have triggered the aggregate 20 ppm threshold.
If the answers to these four questions aren’t clearly documented in the CoA you’ve received, the practical solution is third-party retesting through an ISO 17025-accredited analytical testing laboratory with HPTLC and ICP-MS capability. That’s precisely the model we operate through our Chicago hub: ship to Countryside, IL, and testing is performed at our ISO 17025-accredited California facility. You receive a complete CoA within 5–7 business days — one that documents each monograph test section separately, with method references, instrument data, and acceptance criteria stated explicitly.
The “Meets USP” stamp on a supplier CoA isn’t worthless. But it’s not enough — not for compliance, not for quality assurance, and not for the kind of documentation that holds up when someone in authority asks exactly how you confirmed what you put in your product.
Written by Nour Abochama, VP Operations, Qalitex | Quality Consultant, Ayah Labs. Learn more about our team
Ship your sample to our Chicago facility — get a Qalitex CoA in 5–7 days. Contact us
Related from our network
- ISO 17025 supplement and raw material testing for US brands — Accredited CoA issuance for identity, heavy metals, potency, and microbiology testing with national sample intake
Written by
Nour AbochamaVP Operations, Qalitex | Quality Consultant, Ayah Labs
Chemical engineer with 17+ years of experience in laboratory operations, quality assurance, and regulatory compliance. Expert in herbal and supplement testing, botanical identity, contract laboratory services, and ISO 17025 quality systems. Master's in Biomedical Engineering from Grenoble INP – Ense3. Former Director of Quality at American Testing Labs and Labofine. Executive Producer and co-host of the Nourify-Beautify Podcast.
Related Testing Services
Need contract testing?
Get a quote from Ayah Labs. 48-hour turnaround for chemistry tests. Signed CoA included.
Get a Testing Quote →